Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-13 Purchase |
2021-12-15 5:15 pm |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
3,700 | $10.91 | $40,367 | 3,196,040 (Indirect Direct) |
View |
| 2020-11-03 Purchase |
2020-11-05 6:08 pm |
SQZ Biotechnologies Co | SQZ | Temasek Holdings (Private) Ltd 10% Owner |
625,000 | $16 | $10,000,000 | 2,513,924 (Indirect) |
View |
| 2020-11-03 Purchase(A) |
2020-11-04 4:49 pm |
SQZ Biotechnologies Co | SQZ | AMERICAN INTERNATIONAL GROUP INC 10% Owner |
625,000 | $16 | $10,000,000 | 625,000 (Indirect) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:00 pm |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
250,000 | $16 | $4,000,000 | 2,739,990 (Indirect Direct) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:00 pm |
SQZ Biotechnologies Co | SQZ | Polaris Management Co. VII L.L.C. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners VII L.P. 10% Owner |
250,000 | $16 | $4,000,000 | 2,549,306 (Indirect) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:00 pm |
SQZ Biotechnologies Co | SQZ | Invus Public Equities L.P. Minne Pascal Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Artal Treasury Ltd Invus Public Equities Advisors LLC 10% Owner |
465,000 | $16 | $7,440,000 | 1,606,308 (Direct) |
View |
| 2020-10-30 Purchase |
2020-11-02 4:34 pm |
SQZ Biotechnologies Co | SQZ | AMERICAN INTERNATIONAL GROUP INC 10% Owner |
625,000 | $16 | $10,000,000 | 625,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A 2028-03-04 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
24,130 | $0 | 3,229,480 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
14,039 | $4.59 | 3,229,480 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
10,091 | $2.02 | 3,229,480 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-22 5:15 pm |
N/A 2026-10-10 |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
11,049 | $0 | 455,699 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-22 5:15 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
11,049 | $1.81 | 455,699 (Direct) |
View |
Ownership |
2021-11-16 4:50 pm |
N/A 2031-07-01 |
SQZ Biotechnologies Co | SQZ | Capasso Richard See Remarks |
0 | $0 | 37,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 5:20 pm |
N/A 2031-06-30 |
SQZ Biotechnologies Co | SQZ | VINK PATRICK V.J.J. Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 5:19 pm |
N/A 2031-06-30 |
SQZ Biotechnologies Co | SQZ | Coulie Bernard Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:26 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | Elia Marc Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | SCHEGERIN MARC Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | Srivastava Sapna Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:15 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | Jensen Klavs F. Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:15 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | BOLNO PAUL Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2020-10-29 Option Award(A) |
2021-04-01 5:30 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Zajic Micah Chief Business Officer |
32,643 | $0 | 32,643 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 5:32 pm |
N/A 2026-10-10 |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
8,000 | $0 | 455,699 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 5:32 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
8,000 | $1.81 | 455,699 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:59 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | Knopf Lawrence J General Counsel |
48,100 | $0 | 48,100 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:57 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | Zajic Micah Chief Business Officer |
22,339 | $0 | 22,339 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:57 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | Rosen Oliver Chief Medical Officer |
75,625 | $0 | 75,625 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:55 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | First David Chief People Officer |
28,900 | $0 | 28,900 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:53 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | BERNSTEIN HOWARD PHD MD Chief Scientific Officer |
72,900 | $0 | 72,900 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:50 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | Loxam Teri Chief Financial Officer |
75,950 | $0 | 75,950 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:48 pm |
N/A 2031-02-22 |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
195,000 | $0 | 195,000 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:30 pm |
N/A 2026-10-10 |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
2,500 | $0 | 455,699 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:30 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Sharei Armon President and CEO |
2,500 | $1.81 | 455,699 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-05 6:08 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Temasek Holdings (Private) Ltd 10% Owner |
1,888,924 | $0 | 2,513,924 (Indirect) |
View |
| 2020-11-03 Conversion(A) |
2020-11-04 4:49 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | AMERICAN INTERNATIONAL GROUP INC 10% Owner |
3,159,197 | $0 | 625,000 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Jensen Klavs F. Director |
28,587 | $0 | 338,982 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
5,411,716 | $0 | 2,739,990 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Polaris Management Co. VII L.L.C. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners VII L.P. 10% Owner |
4,830,589 | $0 | 2,549,306 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Invus Public Equities L.P. Minne Pascal Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Artal Treasury Ltd Invus Public Equities Advisors LLC 10% Owner |
2,225,173 | $0 | 1,606,308 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | Amy Schulman as Trustee The Armon R. Sharei Irrevocable GST Trust of 2016 U/D/T Dated December 29 2016 10% Owner |
21,494 | $0 | 385,891 (Direct) |
View |
| 2020-10-30 Conversion |
2020-11-02 4:34 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | AMERICAN INTERNATIONAL GROUP INC 10% Owner |
3,159,197 | $0 | 625,000 (Indirect) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:37 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Moessinger Eric Director |
7,055 | $0 | 7,055 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:35 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
7,055 | $0 | 7,055 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:35 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Jensen Klavs F. Director |
7,055 | $0 | 7,055 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:33 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Knopf Lawrence J General Counsel |
77,922 | $0 | 77,922 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:31 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Loxam Teri Chief Financial Officer |
10,530 | $0 | 10,530 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:30 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | SCHEGERIN MARC Director |
42,120 | $0 | 42,120 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:30 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | BERNSTEIN HOWARD PHD MD Chief Scientific Officer |
10,530 | $0 | 10,530 (Direct) |
View |